(5R)-4,5-DIHYDRO-5-METHYL-5-((4-(4-(4-(TRIFLUOROMETHOXY)PHENOXY)-1-PIPERIDINYL)PHENOXY)METHYL)-2-OXAZOLAMINE
UNII Y569TM2AT2
Substance Identification & Data
This profile provides standardized clinical and technical data for (5r)-4,5-dihydro-5-methyl-5-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-2-oxazolamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y569TM2AT2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1202875-92-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H26F3N3O4 YDAIKJSLITWSBP-JOCHJYFZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (5r)-4,5-dihydro-5-methyl-5-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-2-oxazolamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.